MDLinx and DXY strike China healthcare panel deal
Under the terms of the agreement, DXY will provide verified panel and in-country project management while MDLinx will be responsible for technology and best practice in research.
MDLinx said the deal gives it a total global reach of more than a million healthcare professionals across the US, France, Germany, Italy, the UK, Spain, Japan, South Korea and now China.
We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments